Cargando…

Apples and pears? A comparison of two sources of national lung cancer audit data in England

In 2014, the method of data collection from NHS trusts in England for the National Lung Cancer Audit (NLCA) was changed from a bespoke dataset called LUCADA (Lung Cancer Data). Under the new contract, data are submitted via the Cancer Outcome and Service Dataset (COSD) system and linked additional c...

Descripción completa

Detalles Bibliográficos
Autores principales: Khakwani, Aamir, Jack, Ruth H., Vernon, Sally, Dickinson, Rosie, Wood, Natasha, Harden, Susan, Beckett, Paul, Woolhouse, Ian, Hubbard, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521232/
https://www.ncbi.nlm.nih.gov/pubmed/28748189
http://dx.doi.org/10.1183/23120541.00003-2017
_version_ 1783251933156343808
author Khakwani, Aamir
Jack, Ruth H.
Vernon, Sally
Dickinson, Rosie
Wood, Natasha
Harden, Susan
Beckett, Paul
Woolhouse, Ian
Hubbard, Richard B.
author_facet Khakwani, Aamir
Jack, Ruth H.
Vernon, Sally
Dickinson, Rosie
Wood, Natasha
Harden, Susan
Beckett, Paul
Woolhouse, Ian
Hubbard, Richard B.
author_sort Khakwani, Aamir
collection PubMed
description In 2014, the method of data collection from NHS trusts in England for the National Lung Cancer Audit (NLCA) was changed from a bespoke dataset called LUCADA (Lung Cancer Data). Under the new contract, data are submitted via the Cancer Outcome and Service Dataset (COSD) system and linked additional cancer registry datasets. In 2014, trusts were given opportunity to submit LUCADA data as well as registry data. 132 NHS trusts submitted LUCADA data, and all 151 trusts submitted COSD data. This transitional year therefore provided the opportunity to compare both datasets for data completeness and reliability. We linked the two datasets at the patient level to assess the completeness of key patient and treatment variables. We also assessed the interdata agreement of these variables using Cohen's kappa statistic, κ. We identified 26 001 patients in both datasets. Overall, the recording of sex, age, performance status and stage had more than 90% agreement between datasets, but there were more patients with missing performance status in the registry dataset. Although levels of agreement for surgery, chemotherapy and external-beam radiotherapy were high between datasets, the new COSD system identified more instances of active treatment. There seems to be a high agreement of data between the datasets, and the findings suggest that the registry dataset coupled with COSD provides a richer dataset than LUCADA. However, it lagged behind LUCADA in performance status recording, which needs to improve over time.
format Online
Article
Text
id pubmed-5521232
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-55212322017-07-26 Apples and pears? A comparison of two sources of national lung cancer audit data in England Khakwani, Aamir Jack, Ruth H. Vernon, Sally Dickinson, Rosie Wood, Natasha Harden, Susan Beckett, Paul Woolhouse, Ian Hubbard, Richard B. ERJ Open Res Original Articles In 2014, the method of data collection from NHS trusts in England for the National Lung Cancer Audit (NLCA) was changed from a bespoke dataset called LUCADA (Lung Cancer Data). Under the new contract, data are submitted via the Cancer Outcome and Service Dataset (COSD) system and linked additional cancer registry datasets. In 2014, trusts were given opportunity to submit LUCADA data as well as registry data. 132 NHS trusts submitted LUCADA data, and all 151 trusts submitted COSD data. This transitional year therefore provided the opportunity to compare both datasets for data completeness and reliability. We linked the two datasets at the patient level to assess the completeness of key patient and treatment variables. We also assessed the interdata agreement of these variables using Cohen's kappa statistic, κ. We identified 26 001 patients in both datasets. Overall, the recording of sex, age, performance status and stage had more than 90% agreement between datasets, but there were more patients with missing performance status in the registry dataset. Although levels of agreement for surgery, chemotherapy and external-beam radiotherapy were high between datasets, the new COSD system identified more instances of active treatment. There seems to be a high agreement of data between the datasets, and the findings suggest that the registry dataset coupled with COSD provides a richer dataset than LUCADA. However, it lagged behind LUCADA in performance status recording, which needs to improve over time. European Respiratory Society 2017-07-21 /pmc/articles/PMC5521232/ /pubmed/28748189 http://dx.doi.org/10.1183/23120541.00003-2017 Text en The content of this work is ©the authors or their employers. Design and branding are ©ERS 2017. http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Articles
Khakwani, Aamir
Jack, Ruth H.
Vernon, Sally
Dickinson, Rosie
Wood, Natasha
Harden, Susan
Beckett, Paul
Woolhouse, Ian
Hubbard, Richard B.
Apples and pears? A comparison of two sources of national lung cancer audit data in England
title Apples and pears? A comparison of two sources of national lung cancer audit data in England
title_full Apples and pears? A comparison of two sources of national lung cancer audit data in England
title_fullStr Apples and pears? A comparison of two sources of national lung cancer audit data in England
title_full_unstemmed Apples and pears? A comparison of two sources of national lung cancer audit data in England
title_short Apples and pears? A comparison of two sources of national lung cancer audit data in England
title_sort apples and pears? a comparison of two sources of national lung cancer audit data in england
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521232/
https://www.ncbi.nlm.nih.gov/pubmed/28748189
http://dx.doi.org/10.1183/23120541.00003-2017
work_keys_str_mv AT khakwaniaamir applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT jackruthh applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT vernonsally applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT dickinsonrosie applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT woodnatasha applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT hardensusan applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT beckettpaul applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT woolhouseian applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland
AT hubbardrichardb applesandpearsacomparisonoftwosourcesofnationallungcancerauditdatainengland